SmallCap 60: Ortho Regenerative (ORTH: CSE) (ORTIF: OTCQB) Is Happy With Speed and Process of Clinical Trial Sites
posted on
Jun 24, 2022 02:41PM
Chitogenx is in the regulatory lead for regenerative products + signs MOU with major Medical Institute